CIK 0001661053
- Non-accelerated filer
- Smaller reporting company
enVVeno Medical Corp
Sign in to watch- Ticker
- NVNO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330936180
- Phone
- +1 949-261-2900
- Business address
- 70 DOPPLER, IRVINE, CA, 92618
- Former names
- Hancock Jaffe Laboratories, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $123
- in 1 filing, $123 under 10b5-1 plans
Net −$123. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | Alavi Hamed Chief Technology Officer | Other disposition · Restricted Stock Units | −50,000 | 0 | ||
| 2024-12-18 | Alavi Hamed Chief Technology Officer | Grant or award · Stock Options | +75,000 | 75,000 | ||
| 2024-03-13 | Alavi Hamed Chief Technology Officer | Exercise or conversion | +8,334 | $3.59 | $30K | 8,334 |
| 2024-03-13 | Alavi Hamed Chief Technology Officer | Sale | −8,334 | $6.22 | $52K | 0 |
| 2024-03-13 | Alavi Hamed Chief Technology Officer | Exercise or conversion · Stock Options | −8,334 | 91,666 | ||
| 2023-12-05 | Alavi Hamed Chief Technology Officer | Grant or award · Stock Options | +100,000 | 100,000 |
Page 1 of 1 · 6 trades